TSPTX
Price
$5.71
Change
-$0.06 (-1.04%)
Updated
Jul 13 closing price
Net Assets
82.82M
WCMLX
Price
$15.41
Change
+$0.05 (+0.33%)
Updated
Jul 14 closing price
Net Assets
53.3M
Interact to see
Advertisement

TSPTX vs WCMLX

TSPTX vs WCMLX Comparison Chart in %
View a ticker or compare two or three
VS
TSPTX vs. WCMLX commentary
Jul 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TSPTX is a Buy and WCMLX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TSPTX has more cash in the bank: 82.8M vs. WCMLX (53.3M). TSPTX (0.00) and WCMLX (0.00) have matching dividends . TSPTX was incepted earlier than WCMLX: TSPTX (14 years) vs WCMLX (7 years). WCMLX (1.79) is less costly to investors than TSPTX (1.09). WCMLX is a more actively managed with annual turnover of: 89.00 vs. TSPTX (47.00). TSPTX has a lower initial minimum investment than WCMLX: TSPTX (0) vs WCMLX (100000). WCMLX annual gain was more profitable for investors over the last year : 20.28 vs. TSPTX (-2.86). WCMLX return over 5 years is better than : 2.95 vs. TSPTX (-36.45).
TSPTXWCMLXTSPTX / WCMLX
Total Expense Ratio1.000.99101%
Annual Report Gross Expense Ratio1.091.7961%
Fund Existence14 years7 years-
Gain YTD8.86811.62876%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets82.8M53.3M155%
Annual Yield % from dividends0.000.00-
Returns for 1 year-2.8620.28-14%
Returns for 3 years-13.4925.90-52%
Returns for 5 years-36.452.95-1,236%
Returns for 10 years-55.74N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QSMNX22.43N/A
N/A
AQR Small Cap Multi-Style N
TIHBX16.41N/A
N/A
Transamerica International Stock I
AFEGX52.42N/A
N/A
American Century Large Cap Equity G
FEXRX15.23-0.18
-1.17%
First Eagle U.S. SMID Cap Opportunity R6
CGVYX30.74-0.41
-1.32%
American Funds Global Insight 529-A